1. Introduction {#sec1}
===============

Calibrated fMRI measurement of absolute cerebral rate of oxygen metabolism (CMRO~2~) offers a non-invasive method of mapping oxygen consumption in the brain ([@bib5]; [@bib11]; [@bib55]), providing quantitative estimates of a critical physiological function. However, the method does not directly consider the transport of oxygen into the tissue, which is principally constrained by cerebral blood flow (CBF) and the effective oxygen diffusivity of the capillaries ([@bib7]; [@bib15]; [@bib20]; [@bib26]; [@bib37]; [@bib50]; [@bib52]; [@bib58]). Effective oxygen diffusivity summarises the practical ability of the capillary network for oxygen diffusion into the tissue and limits the speed of oxygen transport out of the microvasculature. One of the primary determinants of the effective oxygen diffusivity is the capillary density ([@bib15]), which is known to be associated with mitochondrial density ([@bib23]) and metabolic demand ([@bib18]). Thus, brain regions with a high resting CMRO~2~ are found to be co-localised with regions of high capillary density ([@bib45]). However, the effective diffusivity does not appear to be a fixed property of the tissue and may play a crucial role in neurovascular coupling, with oxygen diffusivity being observed to parallel increases in demand and compensate for reductions in oxygen delivery ([@bib20], [@bib19]; [@bib26]; [@bib50]).

Compartmental models of oxygen exchange between the capillaries and tissue offer a means of estimating the effective oxygen diffusivity from observations of blood flow and oxygen extraction. The model proposed by ([@bib26]) suggests a need for the effective diffusivity to increase during functional hyperaemia in order to meet the metabolic demands of neural activation. Based on a meta-analysis of CBF and CMRO~2~ measurements from a variety of modalities Hyder et al. proposed a linear coupling between flow and effective diffusivity to account for this apparently coupled behaviour. Evidence for this linear relationship between the effective oxygen diffusivity and CBF was demonstrated with a combined MRI and MRS approach in rat ([@bib25]). However, PET experiments conducted by ([@bib50]) demonstrate a need for the oxygen diffusivity to adapt to the current metabolic demand, with alterations in the effective diffusivity appearing to be made independently from cerebral blood flow. Alternatively, more recent analysis presented by ([@bib6]) demonstrates that metabolic oxygen demand could be met if there was fixed but significant oxygen tissue content, without the need for adjustment to the oxygen diffusivity. The exact mechanism responsible for any such adaptation to metabolic demand is unclear. However, a plausible candidate for the modulation of the effective diffusivity is via pericyte control of capillary dilation, either through a direct increase in the capillary blood volume, or via a homogenisation of flow heterogeneity ([@bib31]). Thus, measurement of the effective diffusivity may in fact provide a non-invasive probe to investigate the health and action of capillary pericytes, whose function is known to be degraded in multiple neurodegenerative diseases and stroke ([@bib54]; [@bib56]; [@bib59]).

In the work presented here we use a compartmental model of oxygen exchange to model the relationship between blood flow, effective diffusivity and oxygen extraction. The model is included within a dual-calibrated fMRI estimation framework ([@bib12]) to enable simultaneous estimates of the resting blood flow, oxygen extraction fraction (OEF), effective diffusivity, and CMRO~2~. The aim of this study was to examine the coupling between consumption (CMRO~2~) and diffusivity at rest, and in response to neural activation (a visual checkerboard task) using the newly proposed method. Our first hypothesis was that, due to the tight functional-structural coupling between capillary density and resting metabolism, there would be a strong correlation between the basal CMRO~2~ and effective diffusivity. Secondly, we hypothesised that the increased metabolic demand due to the visual task would result in a parallel increase in effective diffusivity, whose magnitude should be consistent with published recordings of functional capillary recruitment ([@bib16]).

2. Methods {#sec2}
==========

2.1. Compartmental modelling {#sec2.1}
----------------------------

The compartmental model of oxygen exchange is based on the model of ([@bib20]). As shown in [Fig. 1](#fig1){ref-type="fig"}, the model contains a single capillary compartment with area A and length L, which exchanges oxygen with a cylindrical volume of tissue. The capillary has two compartments, a haemoglobin compartment (with oxygen content C~B~) and a plasma compartment (with oxygen partial pressure P). The oxygen in plasma is assumed to be in equilibrium with the oxygen bound to haemoglobin as described by the Hill equation below$$P = \ P_{50} \cdot \left( {C_{B}/\left( {\varphi \cdot \left\lbrack Hb \right\rbrack - C_{B}} \right)} \right)^{\frac{1}{h}}$$where P is the partial pressure of oxygen in the plasma, P~50~ is the oxygen partial pressure at half saturation, \[Hb\] is the haemoglobin concentration (g/ml), φ is the oxygen binding capacity for Hb (1.34 ml/g), h is the Hill coefficient (2.8), and C~B~ (oxygen bound to haemoglobin) is equal to total capillary oxygen content, C~t~, if the contribution of plasma oxygen is neglected.Fig. 1Schematic of the simple compartmental model for oxygen exchange between capillary blood and brain tissue.Fig. 1

As blood travels along the capillary, the oxygen exchanges between an infinitesimally thin element of blood plasma and a well-stirred oxygen compartment some fixed distance from the capillary (with partial pressure P~m~). The permeability of the capillary endothelium and brain tissue are combined into a single effective permeability, k. This interpretation of the model is a departure from the model presented by ([@bib20]), who assumed a uniform partial pressure of oxygen in the radial slice of plasma and zero partial pressure of oxygen on the tissue side of the capillary-tissue interface, thus, localising the oxygen transport to within the capillary endothelium. However, *in-vivo* measurements suggest that the capillary wall does not present a significant barrier to oxygen diffusion ([@bib9]), which is instead provided by the tissue ([@bib24]). Thus, as per ([@bib26]), we combine both the capillary wall and the surrounding brain tissue into a single interface between the plasma and a well-stirred pool at the end of the diffusion path, which is presumably within or surrounding the mitochondria.

From our compartmental model we can define the differential equation describing the loss of oxygen from within a capillary as$$\left. \frac{dC_{t}\left( {x,t} \right)}{dt} = \  - k\left( P\left( {x,t} \right) \right. - P_{m}\left( t \right) \right)$$where t is time, x is the fractional distance along the capillary (0,1), k is the effective permeability (mL/mmHg/mL/min), P is the oxygen partial pressure in the plasma (mmHg), and P~m~ is the oxygen partial pressure at the mitochondria (mmHg).

Following ([@bib58]) and ([@bib20])$$CBF = \ A \cdot L \cdot \frac{dx}{dt} = \ V \cdot \frac{dx}{dt}$$and when blood flow is constant$$\frac{dC_{t}}{dt} = \ \frac{dC_{t}}{dx} \cdot \frac{dx}{dt}\ $$where CBF is cerebral blood flow in ml/100 g/min, A is the cross-sectional area of the capillary, L is the length, and V is the volume in ml/100g. Thus, by substituting equations [(3)](#fd3){ref-type="disp-formula"}, [(4)](#fd4){ref-type="disp-formula"} into equation [(2)](#fd2){ref-type="disp-formula"} we obtain$$\frac{dC_{t}}{dx} = \  - \frac{k \cdot V}{CBF}\left( {P - P_{m}} \right)$$

If we assume that there is minimal partial pressure of oxygen at the mitochondria ([@bib15], [@bib13]; [@bib21]), i.e. P~m~ ≈ 0, then the product k×V is the effective oxygen diffusivity, D~C~ (ml/100g/mmHg/min). By substituting equation [(1)](#fd1){ref-type="disp-formula"} into equation [(5)](#fd5){ref-type="disp-formula"}, we can express the differential equation of oxygen loss in terms of capillary oxygen content, resting CBF, and the effective oxygen diffusivity as$$\frac{dC_{t}}{dx} = \  - \frac{D_{c} \cdot P_{50}}{CBF} \cdot \left( \frac{C_{t}}{\varphi \cdot \left\lbrack Hb \right\rbrack - C_{t}} \right)^{\frac{1}{h}}$$which is the equivalent to equation [(6)](#fd6){ref-type="disp-formula"} in ([@bib20]), except that we are assuming negligible oxygen tension at the mitochondria rather than zero average oxygen tension in the tissue.

At the macroscopic level we consider a volume of tissue to contain a collection of identical capillaries arranged such that P~m~ can be considered uniform (note this does not pre-suppose any particular structural configuration). For simplicity we also assume that all other parameters are identical across the capillaries, such that there is no flow heterogeneity or variation in haemoglobin concentration \[Hb\]. Thus, the modelled oxygen diffusivity represents a combination of vascular parameters including capillary blood volume, flow heterogeneity, and any underlying variation in P~m~.

Equation [(6)](#fd6){ref-type="disp-formula"} was solved numerically (using MATLAB\'s ordinary differential equation solver (Mathworks, MA, USA.)) for different combinations of D~c~, CBF, P~50~, and \[Hb\] to create a lookup table of results that could be used to fit *in-vivo* data. The oxygen extraction fraction was calculated by evaluating (C~t~(x)\|~x=0~ - C~t~(x)\|~x=1~)/C~t~(x)\|~x=0~ for each combination of parameters, where C~t~(x)\|~x=0~ is the oxygen content at the arterial end of the capillary (CaO~2~), assumed to be 0.95 of the maximum ([@bib31]), and C~t~(x)\|~x=1~ is the oxygen content at the venous end of the capillary (CvO~2~).

2.2. Calibrated fMRI signal modelling {#sec2.2}
-------------------------------------

Quantification of the oxygen extraction fraction and resting blood flow (from which CMRO~2~ is calculated) is performed using the dual-calibrated fMRI method ([@bib5]; [@bib11]; [@bib55]) within a forward modelling framework ([@bib12]). The method is based upon the isometabolic alteration of flow and venous oxygenation using hypercapnic and hyperoxic respiratory modulations. Here we utilise the simplified calibration model ([@bib36]), where the change in BOLD signal is defined by equation [(7)](#fd7){ref-type="disp-formula"}.$$\frac{\Delta S}{S_{0}} = \ TE \cdot \kappa \cdot \left\lbrack {dHb} \right\rbrack_{0}\left\{ {1 - \left( \frac{CBF}{CBF_{0}} \right)^{\theta}\left( \frac{\left\lbrack {dHb} \right\rbrack}{\left\lbrack {dHb} \right\rbrack_{0}} \right)} \right\}$$where S is the MR signal magnitude, TE is the echo time of the acquisition, κ is a composite calibration parameter that represents the combination of the venous-weighted blood volume and water diffusion effects, \[dHb\] is the deoxyhaemoglobin concentration and is equal to \[Hb\]×(1-S~v~O~2~), θ (assigned a value of 0.06) is an empirical parameter combining contributions from venous blood volume changes during hypercapnic hyperaemia and extra-vascular water diffusion effects around the microvasculature, and the subscript 0 represents the a parameter\'s baseline value.

The deoxyhaemoglobin ratio is modelled as shown in equation [(8)](#fd8){ref-type="disp-formula"} ([@bib55]), and as before, OEF = (CaO~2~ -- CvO~2~)/CaO~2~.$$\frac{\left\lbrack {dHb} \right\rbrack}{\left\lbrack {dHb} \right\rbrack_{0}} = \ \frac{CBF_{0}}{CBF} - \frac{1}{\left\lbrack {dHb} \right\rbrack_{0}}\left\{ {\frac{1}{\varphi}\left( {CaO_{2} - \frac{CBF_{0}}{CBF}CaO_{2|0}} \right) + \left\lbrack {Hb} \right\rbrack\left( {\frac{CBF_{0}}{CBF} - 1} \right)} \right\}$$

The arterial spin labelling (ASL) sequence used for the calibrated acquisition uses a pCASL labelling scheme with pre-saturation and background suppression ([@bib41]), and a dual-excitation (DEXI) EPI readout ([@bib44]). As such it differs from the dual-echo PASL acquisition previously employed in the forward modelling framework ([@bib12]), and the methods have been adapted to reflect this. In the current implementation, BOLD contamination is removed from TE~1~ via surround subtraction, and ASL contamination is removed from TE~2~ via surround averaging. Thus, only the BOLD model (equations [(7)](#fd7){ref-type="disp-formula"}, [(8)](#fd8){ref-type="disp-formula"} is used to estimate TE~2~ data, while TE~1~ time courses are estimated according to the simplified pCASL kinetic model ([@bib1]), equation [(9)](#fd9){ref-type="disp-formula"}.$$\Delta S = \ \frac{2 \cdot \alpha \cdot \alpha_{inv} \cdot CBF \cdot T_{1,blood} \cdot M_{0} \cdot \left( {1 - e^{- \frac{\tau}{T_{1,blood}}}} \right)}{6000 \cdot \lambda \cdot e^{\frac{PLD}{T_{1,blood}}}}$$where ΔS is the tag/control difference, α is the tagging inversion efficiency (0.85), α~inv~ is a scaling factor to account for the reduction in tagging efficiency due to background suppression (0.88)([@bib39]; [@bib47]), T~1,blood~ is the longitudinal relaxation time of arterial blood, M~0~ is the equilibrium magnetisation, λ is the brain/blood partition coefficient (0.9), τ is the tagging duration, and PLD is the post labelling delay. See [Table 1](#tbl1){ref-type="table"} for a summary of the parameters used in the modelling of ASL, BOLD and oxygen exchange.Table 1Abbreviations for variables and techniques used in the modelling and analysis.Table 1Variable/abbreviationExpression (units)OEFOxygen Extraction Faction (dimensionless 0--1)CMRO~2~Cerebral Metabolic Rate of Oxygen consumption (μmol/100 g/min)CBFCerebral Blood Flow (ml/100g/mmHg/min)CVRCerebral Vascular Reactivity (% CFB change/mmHg Co~2~)D~c~Effective oxygen diffusivity of the capillary network (ml/100g/mmHg/min)POxygen tension in capillary plasma(mmHg)P~50~Oxygen tension at which haemoglobin is 50% saturated (mmHg)P~m~Oxygen tension at the mitochondria (mmHg)\[Hb\]Haemoglobin concentration (g/ml)C~B~Oxygen content bound to haemoglobin (ml/ml)C~t~Total capillary oxygen content (ml/ml)CaO~2~Oxygen content at the arterial end of the capillary network (ml/ml)CvO~2~Oxygen content at the venous end of the capillary network (ml/ml)SaO~2~Arterial oxygen saturation (dimensionless 0--1)SvO~2~Venous oxygen saturation (dimensionless 0--1)PaO~2~Arterial oxygen tension (mmHg)PaCO~2~Arterial carbon dioxide tension (mmHg)P~ET~O~2~End-tidal oxygen tension (mmHg)P~ET-~CO~2~End-tidal carbon dioxide tension (mmHg)ϕOxygen binding capacity of haemoglobin (1.34 ml/g)hHill coefficient (2.8)kEffective permeability of capillary endothelium and brain tissue (ml/mmHg/ml/min)εOxygen plasma solubility (0.0031 ml/mmHg/dl)BOLDBlood oxygenation level dependent MRI signalASLArterial spin labellingTEEcho time of MRI acquisition (ms)κBOLD calibration parameter including venous-weighted blood volume and water diffusion effects\[dHb\]Deoxyhaemoglobin concentration (g/ml)θEffective hypercapnic venous flow-volume coupling constant (0.06)T~1,blood~Longitudinal relaxation time of arterial blood (s)R~1,blood~Longitudinal relaxation rate of arterial blood (s^−1^)M0MRI signal equilibrium magnetisation (dimensionless)λBrain/blood partition coefficient (dimensionless, 0.9)τArterial spin labelling tagging duration (s)PLDArterial spin labelling post labelling delay (s)

2.3. Data acquisition {#sec2.3}
---------------------

Nineteen healthy volunteers (13 males, mean age 31.9 ± 6.5 years) were recruited to the study. Volunteers\' tolerance of hypercapnic periods and breathing through a face-mask was tested with a non-MRI session prior to MRI scanning. The study was approved by the local ethics committee. Written informed consent was obtained from each participant. All data were acquired using a Siemens MAGNETOM Prisma (Siemens Healthcare GmbH, Erlangen) 3T clinical scanner with a 32-channel receiver head coil (Siemens Healthcare GmbH, Erlangen). During each scanning session an 18-min dual-calibrated fMRI scan was acquired with interleaved periods of hypercapnia, hyperoxia and medical air being delivered to the subjects according to the protocol previously proposed by our lab ([@bib12]). End-tidal gases, P~ET~CO~2~ and P~ET~O~2~, were sampled from the volunteer\'s facemask using a rapidly responding gas analyzer (AEI Technologies, Pittsburgh, PA, USA), see [Fig. 2](#fig2){ref-type="fig"} for a summary of end-tidal recordings and timings of the gas paradigm.Fig. 2Mean (solid line) and standard deviation (shaded area) of end-tidal recordings from all subjects included in analysis (n = 16). Absolute value of end-tidal oxygen partial pressure (red) and relative change in end-tidal carbon dioxide partial pressure (mmHg).Fig. 2

All calibrated fMRI data were acquired using a prototype pCASL acquisition using pre-saturation and background suppression ([@bib41]) and a dual-excitation (DEXI) readout ([@bib44]), see [Fig. 3](#fig3){ref-type="fig"} for a sequence timing diagram. The labelling duration and PLD were both set to 1.5s, GRAPPA acceleration (factor = 3) was used with TE~1~ = 10 ms and TE~2~ = 30 ms. An effective TR (total repetition time including labelling scheme and both readout periods) of 4.4 s was used to acquire 15 slices, in-plane resolution 3.4 × 3.4 mm and slice thickness 7 mm with a 20% slice gap. A calibration (M~0~) image was acquired for ASL quantification with pCASL and background suppression switched off, with TR of 6 s, and TE = 10 ms.Fig. 3Pulse sequence timing diagram for dual-excitation pseudo-continuous arterial spin labelling (DEXI-pCASL) acquisition. Sequence timings are in ms to the nearest 5 ms.Fig. 3

For a subset of volunteers (n = 7, 3 males, mean age 37.4 ± 6.7 years) an additional 8-min black and white visual checkerboard task (reversing at a frequency of 2Hz, alternating between 30 s rest and 30 s stimulus) was performed during pCASL DEXI data acquisition. In each volunteer a T~1~-weighted structural image was acquired for grey matter segmentation and to aid registration to standard (MNI) space.

Blood samples were drawn via a finger prick prior to scanning and were analysed with the HemoCue Hb 301 System (HemoCue, Ängelholm, Sweden) to calculate the systemic \[Hb\] value for each participant. The partial pressures of end-tidal gas concentrations were assumed to be in equilibrium with arterial blood, such that PaO~2~ = P~ET~O~2~ and PaCO~2~ = P~ET~CO~2~. Baseline PaCO~2~ recordings were used to estimate resting blood pH based on the Henderson-Hasselbalch equation (equation [(10)](#fd10){ref-type="disp-formula"}), assuming HCO~3~- = 24 mmol/L ([@bib10]).$$pH = \ 6.1 + log\left\{ {HCO_{3}^{-}/\left( {0.03 \cdot PCO_{2}} \right)} \right\}$$

From which the resting P~50~ was calculated according to the linear correlation, P~50~ = 221.87--26.37×pH, reported by ([@bib10]). The Severinghaus equation ([@bib46]) was used to convert PaO~2~ recordings into SaO~2~ time series, which were then converted to CaO~2~ via equation [(11)](#fd11){ref-type="disp-formula"}.$$CaO_{2} = \ \varphi \cdot \left\lbrack {Hb} \right\rbrack \cdot SaO_{2} + \varepsilon \cdot PaO_{2}$$where ε is the O~2~ plasma solubility (0.0031 ml/mmHg/dL). The T~1~ of arterial blood was calculated from a linear fit to SaO~2~, PaO~2~ and R~1,blood~ in-vivo data presented in ([@bib42]), equation [(12)](#fd12){ref-type="disp-formula"}.$$R_{1,blood} = \ 1.527 \times 10^{- 4} \cdot PaO_{2} + 0.1713 \cdot \left( {1 - SaO_{2}} \right) + 0.5848$$where R~1,blood~ is the longitudinal relaxation rate of arterial blood in seconds.

2.4. Data analysis {#sec2.4}
------------------

Data were pre-processed using a combination of MATLAB code and FSL ([@bib30]). Motion correction was performed with the FSL MCFLIRT function and spatial smoothing (FWHM = 4.5 mm) of the BOLD data (surround average of TE~2~) was performed with SUSAN ([@bib48]). ASL data (surround subtraction of TE~1~) and M~0~ acquisition were spatially smoothed using a 3D Gaussian kernel (FWHM 4.5 mm). DEXI data was registered to the structural T~1~ data using FSL\'s epi-reg tool. Following grey matter segmentation of the structural T~1~ image, using FAST ([@bib57]), grey matter estimates were transformed to native space and used for grey matter masking (threshold of 0.5). DEXI data was masked prior to analysis using a binarised M~0~ image to reduce processing time.

End-tidal traces were aligned with the DEXI data via a cross-correlation between PaCO~2~ and the mean grey matter ASL signal. Measured \[Hb\] and calculated P~50~ values were used to resample the initial 4D effective diffusivity lookup table to a high-resolution 2D lookup table relating CBF~0~ and D~c~ to OEF, enabling simple linear interpolation to be used during fitting. MATLAB\'s non-linear least squares minimisation routine (lsqnonlin) was used to simultaneously optimise voxelwise estimates of D~c~, OEF~0~, CBF~0~, κ, and the cerebral vascular reactivity (CVR) by minimising the least squares difference between the acquired data and modelled ASL and BOLD timeseries (MATLAB code for pre-processing of end-tidal traces and parameter estimation is available from [10.5281/zenodo.1285862](https://doi.org/10.5281/zenodo.1285862){#intref0010} and [10.5281/zenodo.1285845](https://doi.org/10.5281/zenodo.1285845){#intref0015}). See [Fig. 4](#fig4){ref-type="fig"} for a flow diagram representing the forward model used in the analysis framework. In line with the forward modelling approach previously published ([@bib12]) regularisation was applied to reduce instability in fitting a non-linear model to the data (see [appendix](#appsec1){ref-type="sec"} for full details). Briefly, regularisation was applied to D~C~ and OEF in an adaptive manner to reduce the sensitivity to noise variation across voxels and subjects. The regularisation parameter for oxygen extraction fraction was assumed to be uniform, with a nominal OEF~0~ of 0.4. We make the assumption that oxygen diffusivity varies with capillary density (and therefore grey matter partial volume) to impose spatial variation on the diffusivity regularisation. Grey matter partial volume estimates were calculated by normalising an initial perfusion estimate by its maximum value (median value in 100 voxels with greatest signal intensity) and then multiplying by 0.15 ml/100g/mmHg/min. We use an initial perfusion estimate (rather than a segmented structural image) to estimate grey matter partial volume to avoid bias due to segmentation and registration errors. As per our previous work ([@bib12]), we used digital phantom experiments to determine the optimal level of regularisation for each parameter, OEF and D~C~. Additionally, we explored the influence of the SNR on the mean squared error of regularised fits to the simulated data; see the [appendix](#appsec1){ref-type="sec"} for further details of the simulations.Fig. 4Flow diagram showing how measured physiological data and estimated parameters are combined to estimate ASL and BOLD signal time courses during parameter estimation. The forward model incorporates oxygen diffusivity modelling into a dual-calibrated fMRI framework.Fig. 4

Visual data was subject to the same pre-processing steps as the baseline data, additionally it was registered (FLIRT) to baseline data to account for any gross subject motion between the datasets. Percentage change in CBF and the BOLD signals were calculated using FEAT to fit the pre-processed data with the visual paradigm. CMRO~2~ was calculated both on a voxel-wise basis, and from a grey matter ROI, which was thresholded to include only voxels with significant BOLD and CBF activation (z-stats \> 2.3). Because resting data was quantified using a simplified BOLD model ([@bib36]), the standard calibration model ([@bib8]) was modified as per equation [(13)](#fd13){ref-type="disp-formula"} to calculate the visual CMRO~2~.$$CMRO_{2} = CMRO_{2,0} \cdot \ \left( {1 - \frac{\frac{\Delta BOLD}{BOLD_{0}}}{TE \cdot \kappa \cdot \left\lbrack {dHb} \right\rbrack_{0}}} \right) \cdot \left( \frac{CBF}{CBF_{0}} \right)^{1 - \theta}$$

Estimates of CMRO~2~ and CBF during visual activation were used to calculate OEF via the Fick principle, while estimates of D~C~ were made by inverting the look-up table and assuming constant \[Hb\] and P~50~.

3. Results {#sec3}
==========

The mean and standard deviation of baseline P~ET~O~2~ and P~ET~CO~2~ were 116 ± 5 mmHg and 41.6 ± 3.6 mmHg, the hyperoxic respiratory modulation resulted in an average P~ET~O~2~ of 325.2 ± 12.8 mmHg, while hypercapnia produced an average P~ET~CO~2~ of 51.7 ± 3.5 mmHg. Three subjects did not return to a stable P~ET~CO~2~ baseline during the medical air periods of the DEXI acquisition; this was judged to be a deviation of greater than 4 mmHg below the starting value. These subjects were excluded from further analysis. The mean increase in grey matter CBF during hypercapnia was 24.0 ± 3.7%. Group average values of the resting grey matter physiological parameters are reported in [Table 2](#tbl2){ref-type="table"}.Table 2Mean (±standard deviation) systemic and grey matter estimates at baseline, (n = 16).Table 2\[Hb\] g/dlP~50~ mmHgCBF ml/100 g/minOEFCMRO~2~ μmol/100 g/minD~C~ ml/100g/mmHg/minCVR %/mmHg14.3 ± 1.527.1 ± 0.155.6 ± 6.30.38 ± 0.04157.4 ± 12.30.092 ± 0.0092.4 ± 0.4

The mean grey matter value of the effective diffusivity was 0.092 ± 0.01 ml/100g/mmHg/min, or 3.62 ± 0.39 μmol/100g/mmHg/min, which is in good agreement with the PET measurements made by ([@bib28]) and ([@bib50]) who report value of 3.38 and 4.09 respectively. Baseline values of CMRO~2~ are strongly correlated with the effective oxygen diffusivity (R^2^ = 0.81, p \< 0.01), across participants, as shown in [Fig. 5](#fig5){ref-type="fig"}a. This coupling between CMRO~2~ and oxygen diffusivity is also demonstrated within subjects, with a clear spatial similarity between the baseline parameter maps. Example resting parameter maps (CBF~0~, CMRO~2,0~ and D~c,0~) for an individual subject are shown in [Fig. 6](#fig6){ref-type="fig"}. The similarity between the parameter maps is clear, with the maps of effective diffusivity closely following CMRO~2~.Fig. 5Scatter plots of whole brain grey matter parameter estimates at baseline for each subject (n = 16). Top panel (A) demonstrates a strong correlation between baseline metabolic oxygen consumption and effective oxygen diffusivity. Bottom panel (B) shows a strong negative correlation between oxygen extraction and oxygen delivery, such that delivery is elevated when OEF is low.Fig. 5Fig. 6Example baseline (CBF~0~, CMRO~2,0~ and D~c,0~) parameter maps for an individual subject. The spatial similarity between oxygen diffusivity and the basal rate of oxygen metabolism is evidence of a strong structural-functional coupling between the two parameters in the basal state.Fig. 6

While the effective diffusivity appears to be strongly coupled to resting demand, we observed a strong negative correlation between baseline oxygen delivery (CaO~2~×CBF) and oxygen extraction (R^2^ = 0.57, p \< 0.01) ([Fig. 5](#fig5){ref-type="fig"}b). This is consistent with previous findings of a strong negative correlation between OEF~0~ and CBF~0~ ([@bib12]; [@bib35]) when \[Hb\] was assumed to be constant. By incorporating a measured \[Hb\] in the calculation of CaO~2~, the correlation with oxygen delivery is revealed; demonstrating the action of the cerebrovascular system to maintain a tightly controlled resting metabolic rate of oxygen consumption across participants.

To investigate the observed linear relationship between CMRO~2,0~ and D~C,0~, we solved the inverse model with fixed \[Hb\] (14.3 g/dl), P~50~ (27.1 mmHg), and CaO~2,0~ (0.189 ml O2/ml blood). By doing so we are able to examine the modelled co-variance between CMRO~2,0~ and CBF~0~ in isolation of other physiological factors, see [Fig. 7](#fig7){ref-type="fig"}. The analysis suggests a small positive correlation between CBF~0~ and CMRO~2,0~ is required to produce a strictly linear relationship between CMRO~2,0~ and D~C,0~, which agrees well with the in-vivo data (p \< 0.05 for a paired *t*-test comparison between the predicted CBF~0~ and the normalised CBF~0~ estimates (CaO~2,0~ x (CBF~0~/0.189)). However, if the effective oxygen diffusivity is considered to be a constant physiological parameter, as is sometimes assumed ([@bib51]), then a significant non-linear (exponential) relationship is predicted between CBF~0~ and CMRO~2,0~. Finally, we explored a hypothetical scenario in which the inverse of the correlation observed in this study exists between CMRO~2,0~ and D~C,0~. This scenario requires a much larger increase in CBF~0~ with CMRO~2,0~, but it is still mathematically and physiologically feasible to produce such a relationship. This analysis highlights the fact that even though D~C,0~ and CMRO~2,0~ appear to be coupled (in the examined cohort of young healthy volunteers) they provide complementary information, with CMRO~2~ reporting on the rate of oxygen consumption and D~C~ reporting on the ability of the capillary network to supply oxygen to the tissue/mitochondria. The coupling between these parameters is likely the result of the expected correlation between microvascular structure (diffusivity) and function (metabolism).Fig. 7Modelled relationship between CMRO~2,0~ and CBF~0~ for linear increase in D~C,0~ with CMRO~2,0~ (blue), constant D~C,0~ (orange), and linear decrease in D~C,0~ with CMRO~2,0~ (yellow). In-vivo CMRO~2,0~ and normalised CBF~0~ (CaO~2,0~⋅CBF~0~/0.189), mean grey matter values overlaid (circles).Fig. 7

During visual simulation cerebral blood flow increased within the defined ROI (in the primary visual cortex, as expected) by 21.4 ± 4.6%, while CMRO~2~ increased by 15.1 ± 3.5%, resulting in a CBF to CMRO~2~ coupling ratio of 1.44 ± 0.24. The effective oxygen diffusivity was found to increase by 12.5 ± 3.6%. The CMRO~2~ and diffusivity increases are of a similar magnitude to those observed with PET measurements using a 4Hz yellow-blue contrast-reversing checkerboard, where CMRO~2~ and oxygen diffusivity were found to increase by 14.9% and 9.0% respectively. [Fig. 8](#fig8){ref-type="fig"} shows the mean (n = 7) absolute change in physiological parameters evoked by the visual stimulus overlaid onto the selected slice in standard (MNI) space. Changes in diffusivity are co-localised with changes in CMRO~2~, whereas changes in CBF are more widespread.Fig. 8Overlay of the mean absolute change in CBF, CMRO~2~, and effective oxygen diffusivity evoked by the visual checkerboard stimulus for n = 7 subjects.Fig. 8

[Fig. 9](#fig9){ref-type="fig"} shows the correlation between the average CMRO~2~ and effective diffusivity within the visual ROI at baseline (crosses) and during activation (diamonds) for each participant. It is clear from the graph that the coupling between demand and diffusivity, that was previously observed in the grey matter baseline data, is preserved during activation, R^2^ (baseline) = 0.95, R^2^ (activation) = 0.96, p \< 0.01 for both datasets.Fig. 9Summary plot of visual ROI data for CMRO~2~ and effective oxygen diffusivity (including resting and activation data for n = 7 subjects). A tight correlation between CMRO~2~ and effective diffusivity is observed both at baseline (crosses) and during activation (diamonds), indicative of a tight coupling between the effective diffusivity and oxygen demand. The dashed lines are lines of best fit (linear regression) the dotted lines connect baseline and activation data for each subject.Fig. 9

Under the assumption that P~m~ is minimal and the effective permeability is held constant during activation, the apparent change in capillary blood volume is linearly related to the effective diffusivity (see equations [(5)](#fd5){ref-type="disp-formula"}, [(6)](#fd6){ref-type="disp-formula"}). Thus, we can calculate the apparent flow-volume coupling relationship, CBV/CBV~0~ = (CBF/CBF~0~)^η^, implied from the diffusivity data. Using this line of reasoning we find that a coupling constant of 0.62 ± 0.13 is required, relating the 21% flow change to an apparent 12.5% volume increase. This result agrees surprisingly well with in-vivo observations of functional capillary vasodilation. Where the 6.7% increase in capillary diameter observed by ([@bib16]) was calculated to produce a 19% increase in blood flow according to Poiseuille\'s law. Assuming constant capillary length this observation would predict a flow-volume coupling exponent of approximately 0.75 for their data.

4. Discussion and conclusions {#sec4}
=============================

In this manuscript we have presented a novel framework for the analysis of dual-calibrated data to produce simultaneous estimates of CMRO~2~ and effective oxygen diffusivity. The combined analysis of these two physiological parameters has the potential to provide useful insight into the underlying metabolic and vascular responses to different brain states and disease. The method was applied at rest and in combination with a visual task. The resting data showed a tight coupling between grey matter diffusivity and the basal rate of oxygen metabolism. This result is expected in the healthy brain, as there is significant evidence of a structural link between the density of capillaries (a significant determinant of the effective diffusivity) and metabolism ([@bib14]; [@bib18]; [@bib45]).

The effective diffusivity was also found to increase during functional activation, with a 12.5% increase in diffusivity being associated with a 15.1% increase in CMRO~2~ and 21.4% increase in CBF. The coupling ratio between CBF and CMRO~2~, 1.44, is at the lower end of *in-vivo* observations, which typically range from 1.3 to 5 for MRI methodologies ([@bib34]). Thus, the change in effective diffusivity is likely to be at the higher end of the expected range (in order to meet the oxygen demands of the elevated CMRO~2~ in the absence of a greater increase in CBF). Possible mechanisms to provide such an increase in effective diffusivity include a direct increase in capillary blood volume ([@bib26]), a homogenisation of capillary flow heterogeneity ([@bib31]), a reduction in the mitochondrial oxygen tension ([@bib13]), or a high resting tissue oxygen tension ([@bib6]). While each of these factors could play a role in modulating the diffusivity of the capillary network, *in-vivo* measurements suggest that tissue oxygenation initially increases during functional activation and then normalises to a level slightly above its resting value ([@bib2]). Thus, it is unlikely that there is a significant reduction in mitochondrial oxygen tension, which would be expected to lower tissue oxygenation rather than increase it. Alternatively, a high resting mitochondrial oxygen tension would result in a small vessel-to-tissue PO~2~ gradient, which, as highlighted by ([@bib25]), increases the effectiveness by which CBF can increase O~2~ delivery to the tissue. Our model predicts that the mitochondrial oxygen tension would need to be unrealistically high, approximately 30 mmHg to explain the CBF/CMRO~2~ increases observed in this study. While there is uncertainty in the value of P~m~ in the human brain, animal studies suggest that it is between 0.1 and 10 mmHg ([@bib21]), thus a significant resting mitochondrial oxygen tension is unlikely. An alternative explanation explored in this paper is that there is a direct increase in capillary blood volume, potentially mediated by capillary pericytes; which have been demonstrated to alter capillary volume independently of arteriolar dilation ([@bib38]) and appear to play a significant role in neurovascular coupling ([@bib32]). For a given rate of perfusion, an increase in capillary volume would increase the mean transit time for blood to transverse the capillary network, producing a proportional increase in the effective diffusivity, and thus enabling greater extraction of the oxygen from the capillary bed. Our data suggest that a flow-volume coupling exponent of approximately 0.62 is required in the capillaries to provide the observed increase in effective diffusivity during visual stimulation. The implied 12.5% increase in capillary blood volume agrees well with the data and analysis presented by ([@bib16]) in the mouse brain, suggesting this is a plausible explanation for the observed increase in diffusivity. Indeed more recent studies in the mouse brain suggest that such an increase in capillary blood volume is well within the range of normal physiological responses, where capillary volume has been found to increase by 10--26% during functional activation depending on the baseline diameter ([@bib29]).

Although modulation of capillary blood volume appears to be sufficient to provide local control of capillary diffusivity, we cannot rule out a contribution from flow heterogeneity ([@bib31]), which is likely to be reduced during functional activation where smaller capillaries have been observed to dilate more than larger capillaries in rat ([@bib33]; [@bib49]). However, the influence of flow heterogeneity is known to be dependent on the transit time distribution ([@bib3]), and confounding factors such as the heterogeneity of \[Hb\] have not been considered in the modelling, thus it is still unclear if this theoretical model of control is realised *in-vivo*.

As previously discussed, there is unlikely to be a significant resting P~m~ in the studied cohort, meaning the assumption of negligible P~m~ is unlikely to impact the results. However, this may not always be true. In theory P~m~ could increase in the presence of significant mitochondrial dysfunction due to the lack of oxygen uptake in the mitochondria. Currently the only direct evidence we are aware of for an increase in tissue (and therefore most likely mitochondrial) oxygen tension during mitochondrial dysfunction is from simulated dysfunction (due to a cyanide infusion) in piglets ([@bib40]). However, there is increasing evidence of mitochondrial dysfunction in a number of neurodegenerative diseases such as Parkinson\'s disease ([@bib43]) and Alzheimer\'s disease ([@bib53]). Therefore, it should be highlighted that reductions in basal D~C~ may not always correspond to a purely vascular origin and may also incorporate mitochondrial dysfunction.

In line with our previously published methods for analysis of dual-calibrated data ([@bib12]; [@bib55]) we have included priors to stabilise the fitting process (see [appendix](#appsec1){ref-type="sec"}). In the current implementation the priors are incorporated into parameter estimates via adaptive regularisation. Whenever priors are used to guide the fitting process there is always a trade off to be made between overfitting (not enough regularisation) and underfitting (too much regularisation). Digital phantom simulations were used to optimise the amount of regularisation and balance this trade-off. The proposed method employs regularisation on two parameters, the resting OEF and the effective diffusivity. In the case of underfitting we would expect the results to closely follow the prior, thus there would be little variation in OEF or the effective diffusivity between subjects. In contrast we find that OEF is highly correlated with resting oxygen delivery, and the effective diffusivity is tightly coupled to the resting CMRO~2~. Thus, it is unlikely that the results are significantly affected by underfitting. While we cannot rule out overfitting of the data, the appearance of the parameter maps is physiologically plausible and they do not suffer from significant instability within the grey matter. To further explore the influence of the proposed framework on the parameter estimates we performed simulations where D~C~ was not estimated. In this implementation OEF was estimated directly as in ([@bib12]), and thus no regularisation was/could be placed on D~C~. These simulations (see [appendix](#appsec1){ref-type="sec"}) showed similar levels of error to the proposed method, albeit with slightly increase RMSE in OEF estimates at low tSNR.

In conclusion, we have presented an MRI method for mapping the effective oxygen diffusivity of the capillary bed in combination with metabolic oxygen consumption. The method shows good agreement with PET literature and inferred changes in capillary blood volume are in agreement with two-photon laser microscopy measurements in animals, however, direct validation of the method is still outstanding. The proposed method is non-invasive and can be performed in a short timeframe. Previous measurements of effective oxygen diffusivity suggest it may be a valuable tool to understand the brain\'s response to altered oxygen supply and demand. Thus, the introduction of this method could offer a useful insight into a range of conditions and diseases with altered metabolism or vascular function.

Appendix. Digital phantom simulations {#appsec1}
=====================================

We can model the observed MRI data, ASL and BOLD signals that we wish to fit, via equation [(A1)](#fdA1){ref-type="disp-formula"}.$$Y_{i} = f\left( {w_{i},X} \right) + e_{i},\ e \sim N\left( {0,\sigma^{2}} \right)$$Where Y represents the observed MRI signal data, X represents the corresponding physiological traces and their derived parameters (see [Fig. 2](#fig2){ref-type="fig"}), w is a vector of physiological parameters, e is signal noise with zero mean and an unknown variance σ^2^, and *i* is the voxel index.

In order to estimate the physiological parameters, *w*, we perform regularised non-linear least squares minimisation (via MATLAB\'s lsqnonlin function), as defined by equation [(A2)](#fdA2){ref-type="disp-formula"}.$$w_{i|RLS} = \min\limits_{w}\left( {\parallel f\left( {w_{i},X} \right) - Y_{i} \parallel_{2}^{2} + \lambda{\widehat{\sigma}}_{i}^{2} \parallel w_{i}^{'} - v_{i} \parallel_{2}^{2}} \right)$$Where w~i\|RLS~ is the regularised least squares estimate of the physiological parameters at the *i*th voxel. λ is a vector of regularisation coefficient, ${\widehat{\sigma}}^{2}$ is a voxelwise estimate of noise variance (calculated from the variance of the residuals), w' is a vector comprising the parameter estimates for D~C~ and OEF, and v is a vector of the corresponding expected values. The expected value for OEF is set to 0.4 for all voxels (representing a nominal OEF near the mid-point of the physiological range), while the expected value for diffusivity estimates are linearly related to voxel-wise grey matter partial volume estimates. In this way we impose a prior belief that the effective diffusivity will be linearly related to grey matter content (due to the associated relationship with CBV). The expected value for pure grey matter voxels is set to a nominal D~C~ value of 0.15 ml/100g/mmHg/min, corresponding to an OEF of 0.35 ([@bib27]), when Hb = 0.15 g/ml, P~50~ = 26 mmHg, and CBF = 90 ml/100 g/min ([@bib4]).

Because the noise variance is estimated on a voxel-wise basis the regularisation is spatially adaptive; with greater regularisation applied when the noise variance estimate is greater. It should also be noted that the magnitude of the regularisation reduces as the minimisation routine approaches the solution, which has been shown to reduce the bias at convergence ([@bib22]). The value of the regularisation coefficients λ~Dc~ and λ~OEF~, which define the vector λ, were determined from digital phantom simulations, as described below.

Simulated phantoms were created with 245 time points (matching the in-vivo acquisition), for both the ASL and BOLD data, and 4200 elements. Effective diffusivity values were randomly chosen in the range 0.03--0.18, OEF values were assigned values from 0.25 to 0.55, Hb was set to 0.15 g/ml, P~50~ was set to 26 mmHg, if any combination of values implied a CBF below 20 or above 150 ml/100 g/min (according to the flow-diffusion modelling) another value was randomly chosen until this criteria was met. The tSNR of the simulated data was set to match that of the acquired data (after spatial smoothing), which were approximately 4.5 for the ASL data and 150 for the BOLD data. In order to match to in-vivo noise statistics, simulated ASL and BOLD time series were band-pass filtered with a second order infinite impulse response filter using the MATLAB 'designfilt' function. The relative bandpass frequencies were 0.08--0.2 for the ASL data and 0.01 to 0.2 for the BOLD data (pass band ripple 1 dB in each case).

The RMS error in OEF and D~C~ estimates were calculated for varying levels of regularisation under two conditions; with regularisation applied only to OEF and with regularisation applied only to D~C~. Thus, optimising the required regularisation for each parameter separately. By analogy to the standard L-curve method ([@bib17]), the optimal level of regularisation was chosen to be the maximum of the curvature of the λ vs RMS error plot (see [figures A1 and A2](#appsec1){ref-type="sec"}). Thus, selecting the transition point above which further regularisation ceases to provide significant reductions in RMS error. Because we are optimising the regularisation for two parameters (and in two conditions), there are two transition points to choose between in each condition. To minimise the chances of underfitting we chose the point that corresponds to the smallest amount of regularisation in each case.Fig. A1Plot of λ~OEF~ vs. curvature of rms error for effective diffusivity (solid line) and OEF (dashed line). The curvature of the diffusivity error reaches a maximum before the curvature of the OEF error, therefore this point (0.03) was chosen for lambda.Fig. A1Fig. A2Plot of λ~D~c vs. curvature of rms error for effective diffusivity (solid line) and OEF (dashed line). The curvature of the diffusivity error reaches a maximum marginally before the curvature of the OEF error. The peak of the D~C~ curvature is at approximately 1.8 × 10^−3^, and therefore this value is used to set the level of regularisation for D~C~ estimates.Fig. A2

Having optimised λ for a fixed tSNR we explored the noise sensitivity of OEF and D~C~ estimates for ASL tSNR ranging from 0.5 to 8.5 (BOLD tSNR was linearly scaled with ASL tSNR and so ranged from 17 to 280). The results of these simulations are shown in [figure A3](#appsec1){ref-type="sec"} and demonstrate a non-linear increase N-RMSE for both OEF and D~C~ as the tSNR is reduced. It is apparent from the simulation that there is less uncertainty in OEF estimates, with a 15% error occurring for a tSNR of approximately 3, while D~C~ requires a tSNR of approximately 5 to achieve the same level of uncertainty. For comparison with previous methods, which do not fit for D~C~, we have also included the error in OEF estimates when fitting for OEF directly. This is equivalent to the implementation in ([@bib12]), but with adaptive (rather than fixed) regularisation placed only on OEF. The regularisation for this approach was tuned to match the current implementation when the ASL tSNR = 4.5. As can be seen from the plot, the error in OEF estimates are similar to the newly proposed method, with a slight reduction for high tSNR and a decrease in performance for low tSNR. This decrease in performance for low tSNR is likely due to the convergence of the fit to a uniform prior, rather than a prior informed by the estimate of baseline CBF.Fig. A3Plot of normalised RMSE in OEF and D~C~ predicted with varying levels of tSNR (ASL) from digital phantom simulations.Fig. A3
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